Clinical Trial Update: Study to Assess Efficacy and Safety of BNX Sublingual Tablets for the Induction of Treatment of Opioid Dependence [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and safety of BNX Sublingual Tablets for induction therapy in opioid dependence; study completed and results posted in 2015…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Opioid Dependence
• Opioid-related Disorders

Drugs mentioned

• BNX Sublingual Tablets (buprenorphine-naloxone)

Snippet

Sponsor: Orexo AB | Conditions: Opioid-Related Disorders, Opiate Dependence | Phase 3 | Status: COMPLETED | Results posted: 2015-06-24